American Century Companies
VRNA

American Century Companies’s Verona Pharma VRNA Stock Holding History

American Century Companies’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-279,652
Closed -$26.4M – 2887
2025
Q2 		$26.4M Sell
279,652
-29,168
-9% -$2.16M 0.01% 952
2025
Q1 		$19.6M Sell
308,820
-310,985
-50% -$18.6M 0.01% 1042
2024
Q4 		$28.8M Sell
619,805
-256,799
-29% -$9.64M 0.02% 881
2024
Q3 		$25.2M Sell
876,604
-1,439
-0.2% -$35.4K 0.01% 919
2024
Q2 		$12.7M Buy
878,043
+317,184
+57% +$4.63M 0.01% 1148
2024
Q1 		$9.02M Buy
560,859
+31,162
+6% +$539K 0.01% 1244
2023
Q4 		$10.5M Buy
529,697
+249,571
+89% +$3.68M 0.01% 1122
2023
Q3 		$4.57M Buy
+280,126
New +$5.39M ﹤0.01% 1367

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Century Companies's VRNA Position: Q3 2025 in Review

American Century Companies sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 279,652 shares — an estimated $26.4M sold.

American Century Companies first reported a position in VRNA in Q3 2023 and held it in 8 quarters. The position peaked at $28.8M in Q4 2024. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • American Century Companies reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • American Century Companies sold 279,652 Verona Pharma shares in Q3 2025, an estimated $26.4M.
  • American Century Companies first reported a position in Verona Pharma in Q3 2023 and held it in 8 quarters.
  • American Century Companies's Verona Pharma position peaked at $28.8M in Q4 2024.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on American Century Companies's 13F filing for Q3 2025, filed 12 Nov 2025.